pubmed-article:19817530 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19817530 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19817530 | lifeskim:mentions | umls-concept:C2267235 | lld:lifeskim |
pubmed-article:19817530 | lifeskim:mentions | umls-concept:C0949415 | lld:lifeskim |
pubmed-article:19817530 | lifeskim:mentions | umls-concept:C0037747 | lld:lifeskim |
pubmed-article:19817530 | lifeskim:mentions | umls-concept:C0041703 | lld:lifeskim |
pubmed-article:19817530 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19817530 | pubmed:dateCreated | 2009-10-12 | lld:pubmed |
pubmed-article:19817530 | pubmed:abstractText | Limitations of vitamin K antagonists (VKAs) include frequent monitoring, dietary restrictions and drug interactions. This study conducted an indepth exploration of perspectives of VKA therapy in respondents with atrial fibrillation or venous thromboembolism. | lld:pubmed |
pubmed-article:19817530 | pubmed:language | eng | lld:pubmed |
pubmed-article:19817530 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19817530 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19817530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19817530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19817530 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19817530 | pubmed:month | Oct | lld:pubmed |
pubmed-article:19817530 | pubmed:issn | 1744-8379 | lld:pubmed |
pubmed-article:19817530 | pubmed:author | pubmed-author:WildDianeD | lld:pubmed |
pubmed-article:19817530 | pubmed:author | pubmed-author:DonattiChrist... | lld:pubmed |
pubmed-article:19817530 | pubmed:author | pubmed-author:MurrayMiranda... | lld:pubmed |
pubmed-article:19817530 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19817530 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:19817530 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19817530 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19817530 | pubmed:pagination | 467-74 | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:meshHeading | pubmed-meshheading:19817530... | lld:pubmed |
pubmed-article:19817530 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19817530 | pubmed:articleTitle | Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain. | lld:pubmed |
pubmed-article:19817530 | pubmed:affiliation | Oxford Outcomes Ltd, Seacourt Tower, West Way, Oxford OX2 OJJ, UK. diane.wild@oxfordoutcomes.com | lld:pubmed |
pubmed-article:19817530 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19817530 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |